Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)
Stopped early · Phase 3
Conditions studied: Diffuse Large B-Cell Lymphoma
In brief
Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in combination with various agents for the treatment of Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL).
Key facts
- Study ID
- NCT02951156
- Run by
- Pfizer
- People needed
- 29
- Starts
- 2016-12-16
- Expected to finish
- 2019-12-02
- Last updated by the study team
- 2020-12-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- City of Hope — Duarte, California, United States
- Norton Cancer Institute — Louisville, Kentucky, United States
- Norton Diagnostic Center - Dupont — Louisville, Kentucky, United States
- Norton Women's and Children's Hospital — Louisville, Kentucky, United States
- Tulane Medical Center — New Orleans, Louisiana, United States
- Parexel International — Billerica, Massachusetts, United States
- University of Michigan Health System — Ann Arbor, Michigan, United States
- Mayo Clinic — Rochester, Minnesota, United States
- North Shore Hematology Oncology Associates — East Setauket, New York, United States
- St. George Hospital — Kogarah, New South Wales, Australia
- Monash Health — Clayton, Victoria, Australia
- Cancer Clinical Trials Centre, Austin Health, Level 4 — Heidelberg, Victoria, Australia
- Genesis Care — Heidelberg, Victoria, Australia
- UZ Gent — Ghent, Belgium
- UZ Leuven — Leuven, Belgium
- Farmacia Studi Clinici — Rozzano, MI, Italy
- Istituto Clinico Humanitas — Rozzano, MI, Italy
- Malopolskie Centrum Medyczne S.C. — Krakow, Lesser Poland Voivodeship, Poland
- Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli — Lublin, Lublin Voivodeship, Poland
- Nzoz McD Voxel Osrodek Pet-Tk-Nmr — Krakow, Poland
- Centrum Onkologii Ziemi Lubelskiej im. Sw. Jana z Dukli Oddzial Hematologiczny — Lublin, Poland
- NU-MED Centrum Diagnostyki i Terapii Onkologicznej Zamosc Sp. z o.o. — Zamość, Poland
- Samsung Medical Center Clinical Trial Pharmacy — Seoul, South Korea
- Samsung Medical Center — Seoul, South Korea
- Hospital San Pedro de Alcantara — Cáceres, Spain
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.